A31T (p.Ala31Thr) variant of SLC35A2 (UDP-galactose translocator)
A31T (p.Ala31Thr) in SLC35A2 (UDP-galactose translocator) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.35 / 1. The record also includes population frequency data and structural context.
A31T (p.Ala31Thr) variant details
- p.Ala31Thr
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.355
- REVEL 0.14
- CADD 33.00
- PolyPhen-2 0.00
- SIFT 0.43
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available